Mirum Pharmaceuticals, Inc.
MIRM
$68.95
-$1.14-1.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.09% | 14.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.09% | 14.52% | |||
| Cost of Revenue | 9.03% | 1.75% | |||
| Gross Profit | 2.98% | 17.84% | |||
| SG&A Expenses | -2.17% | 9.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.78% | 4.74% | |||
| Operating Income | 152.17% | 67.14% | |||
| Income Before Tax | 148.42% | 60.00% | |||
| Income Tax Expenses | -165.17% | -60.93% | |||
| Earnings from Continuing Operations | 149.56% | 60.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 149.56% | 60.07% | |||
| EBIT | 152.17% | 67.14% | |||
| EBITDA | 712.09% | 111.69% | |||
| EPS Basic | 148.69% | 60.73% | |||
| Normalized Basic EPS | 147.52% | 60.69% | |||
| EPS Diluted | 142.41% | 60.73% | |||
| Normalized Diluted EPS | 142.27% | 60.69% | |||
| Average Basic Shares Outstanding | 1.83% | 1.71% | |||
| Average Diluted Shares Outstanding | 14.61% | 1.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||